Abstract
The Japanese cedar pollen (JCP) sublingual immunotherapy (SLIT) tablet (5,000 JAU Torii, Japan/ALK, Denmark) has been available for Japanese cedar pollinosis in Japan since 2018. Post-marketing surveillance of the JCP SLIT tablets has been initiated to investigate the safety and efficacy during two seasons.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
